Spots Global Cancer Trial Database for bendamustine hcl
Every month we try and update this database with for bendamustine hcl cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab | NCT00139841 | Non-Hodgkin's L... | Bendamustine HC... | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer | NCT00867503 | Ovarian Cancer | Bendamustine HC... | 18 Years - | University of Arizona | |
Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma | NCT01570049 | Non-Hodgkin Lym... | Bendamustine | 18 Years - 75 Years | Shandong Lanjin Pharmaceuticals Co.,Ltd | |
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer | NCT00867503 | Ovarian Cancer | Bendamustine HC... | 18 Years - | University of Arizona | |
Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant | NCT01437709 | Mantle Cell Lym... | Ofatumumab (Thi... Ofatumumab + Be... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma | NCT01570049 | Non-Hodgkin Lym... | Bendamustine | 18 Years - 75 Years | Shandong Lanjin Pharmaceuticals Co.,Ltd |